Allen Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$294K Hold
1,125
– – 0.14% 47
2026
Q2
$283K Hold
1,125
– – 0.14% 51
2026
Q1
$245K Hold
1,125
– – 0.12% 58
2025
Q4
$257K Sell
1,125
-184
-14% -$41.9K 0.15% 56
2025
Q3
$303K Sell
1,309
-80
-6% -$16.3K 0.21% 52
2025
Q2
$258K Sell
1,389
-50
-3% -$9.29K 0.18% 53
2025
Q1
$301K Hold
1,439
– – 0.21% 49
2024
Q4
$256K Hold
1,439
– – 0.18% 54
2024
Q3
$284K Buy
1,439
+200
+16% +$37.3K 0.2% 53
2024
Q2
$213K Sell
1,239
-16
-1% -$2.65K 0.19% 58
2024
Q1
$229K Buy
+1,255
New +$216K 0.2% 57

Other funds holding ABBV

Allen Wealth Management's ABBV Position: Q3 2026 in Review

Allen Wealth Management held its AbbVie (ABBV) position steady in Q3 2026 at 1,125 shares worth $294K. The position accounts for 0.14% of the portfolio, ranked #47.

Allen Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. The position peaked at $303K in Q3 2025. 2,287 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Allen Wealth Management held 1,125 shares of AbbVie worth $294K as of Q3 2026.
  • Allen Wealth Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.14% of Allen Wealth Management's portfolio in Q3 2026, its #47 holding.
  • Allen Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
  • Allen Wealth Management's AbbVie position peaked at $303K in Q3 2025.
  • 2,287 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Allen Wealth Management's 13F filing for Q3 2026, filed 29 Oct 2026.